Skip to content

Investigate anesthesia effect of epidural administration of different doses of hydromorphone in caesarean section of patients with preeclampsia

Investigate anesthesia effect of epidural administration of different doses of hydromorphone in caesarean section of patients with preeclampsia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030973
Enrollment
Unknown
Registered
2020-03-20
Start date
2020-04-01
Completion date
Unknown
Last updated
2020-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclampsia

Interventions

Group A:0.1mg hydromorphone
Group B:0.2mg hydromorphone
Group C:0.3mg hydromorphone
Group D:0.4mg hydromorphone

Sponsors

International Peace Maternal and child health care institute affiliated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Pre-eclampsia patients aged 20-40 years; 2. ASA level 2~3; 3. Who are required to undergo cesarean section; 4. Patients requiring cesarean section.

Exclusion criteria

Exclusion criteria: 1. Pregnant women with contraindications of spinal anesthesia; 2. Extremely obese parturient(BMI >=32) and with other diseases.

Design outcomes

Primary

MeasureTime frame
VAS scores;sensory level of analgesia;adverse reaction;

Secondary

MeasureTime frame
uterus constraction;Apgar score;

Countries

China

Contacts

Public ContactZeyong Yang

International Peace Maternal and child health care institute affiliated to Shanghai Jiaotong University School of Medicine

yankylge@aliyun.com+86 13381827292

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026